How have KURA and PRCT total returns compared?

Over the past 5 years, KURA delivered -10.73% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Kura Oncology, Inc. (KURA) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of Kura Oncology, Inc. and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KURA

Kura Oncology, Inc.

$926M

$10.43HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

PRCT

PROCEPT BioRobotics Corporation

$989M

$17.38HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT

Total return — KURA vs PRCT

growth of $100 · dividends reinvested · last 5y

KURA -46.5% (-11.8%/yr)PRCT -57.5% (-15.7%/yr)KURA compounded faster over this window

KURA PRCT

KURA vs PRCT: by the numbers

•PRCT is the larger company ($989M vs $926M market cap).
•Both run net losses; PRCT's is the smaller (-32.54% vs -384.30% net margin).

Metrics side by side

Valuation

Metric	KURA	PRCT
P/S ratio	11.99	2.93
P/B ratio	19.12	2.91

Profitability

Metric	KURA	PRCT
Gross margin	94.73%	63.74%
Operating margin	-449.94%	-33.86%
Net margin	-384.30%	-32.54%
ROE	-612.78%	-32.27%
ROIC	-67.13%	-27.51%

Growth (annualized)

Metric	KURA	PRCT
Revenue CAGR (5Y)	N/A	74.27%
Total return CAGR (5Y)	-10.73%	-14.36%

Frequently asked

How have KURA and PRCT total returns compared?: Over the past 5 years, KURA delivered -10.73% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KURA analysis Full PRCT analysis Interactive comparison tool

Dig into the metrics

Kura Oncology ROE PROCEPT BioRobotics ROE Kura Oncology operating margin PROCEPT BioRobotics operating margin Kura Oncology revenue growth PROCEPT BioRobotics revenue growth Kura Oncology free cash flow PROCEPT BioRobotics free cash flow

Kura Oncology & PROCEPT BioRobotics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.